On the first day of a critical hearing, Kroger attorney Matthew Wolf told the court "this merger will not occur" if the company got an unfavorable ruling. The proceeding, which is expected to last ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any liability in ...

GameStop announced an offering of up to 20 million shares. In Q2, GameStop reported revenue of $798.3 million, compared to $1 ...

Pfizer is hoping to beat rivals including GSK to regulatory approval of its RSV vaccine, claiming first-mover advantage in a market that a market estimated to have the potential to reach a value ...

For example: For all adults aged 60 and older, the societal cost per QALY saved was $196,842 for GSK's Arexvy and $176,557 for Pfizer's Abrysvo. For adults aged 65 and older, the cost was lower at ...

Meningococcal VaccinesGlobal Strategic Business Report to 2030 Featuring Baxter International, Bio-Med, GlaxoSmithKline, Pfizer, Sanofi, and Serum Institute of India Among Others GlobeNewswire (Press ...

GlaxoSmithKline Holdings Inc., Pfizer Inc., Sanofi-Aventis U.S. LLC, and Sanofi US Services Inc. as the defendants. GlaxoSmithKline, Pfizer and Sanofi argued in their motion to dismiss that the ...

In first-half 2024, Pfizer recorded nearly $3.1 billion from combined sales of Prevnar 13 and Prevnar 20, up 2% (excluding Fx) from the year-ago period. GSK plc GSK has a 24-valent PCV in its ...